Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An interesting case of rifampicin-dependent/-enhanced multidrug-resistant tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease - 1 Jan 2010

Zhong M, Zhang X, Wang Y, Zhang C, Chen G, Hu P, Li M, Zhu B, Zhang W, Zhang Y

Abstract excerpt

We report a case of rifampicin (RMP) dependent/enhanced multidrug-resistant (MDR-TB) from a patient who had been treated with the World Health Organization optional thrice-weekly treatment and document the clinical and bacteriological features. RMP-enhanced tubercle bacilli that grew poorly witho...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotics, Antitubercular
Share to Bacterial Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA-Directed RNA Polymerases

Share to Mutation

Share to Mycobacterium tuberculosis

Share to Rifampin

Share to Treatment Failure

Share to Tuberculosis, Multidrug-Resistant

Source

Identifiers

PMID: 20003693

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20003693-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An interesting case of rifampicin-dependent/-enhanced multidrug-resistant tuberculosis.PMID 20003693Read ↗

Mechanisms and detection methods of Mycobacterium tuberculosis rifampicin resistance: The phenomenon of drug resistance is complex.Semantic proximity Read ↗

Totally drug-resistant tuberculosis and adjunct therapies.Semantic proximity Read ↗

Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.Semantic proximity Read ↗

Successful Treatment with a High-dose Rifampin-containing Regimen for Pulmonary Tuberculosis with a Disputed rpoB Mutation.Semantic proximity Read ↗

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF.Semantic proximity Read ↗

Disputed rpoB Mutations in Mycobacterium tuberculosis and Tuberculosis Treatment Outcomes.Semantic proximity Read ↗

TB Anywhere, TB Everywhere. The First Case of pre-Extensively Drug Resistant Tuberculosis Treated with BPaL in Italy: Challenges and Opportunities for Transborder Collaboration.Semantic proximity Read ↗

Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis.Semantic proximity Read ↗

Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure.Semantic proximity Read ↗

A case study of disseminated coccidioidomycosis following anti-TB treatmentSemantic proximity Read ↗

Unveiling the physiological mechanisms that drive the emergence of antibiotic resisters from antibiotic persister population of mycobacteriaSemantic proximity Read ↗

Insights into RpoB clinical mutants in mediating rifampicin resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.